FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

AMGN

AmgenNASDAQ · Biotechnology · Health Care
Previous close
376.35
Change
+0.70 / +0.19%
FinDog View
Neutral
52-Week Range
269.77 – 447.03
P/E (TTM)
23.3
Forward P/E
16.9
Based on consensus earnings for the next 12 months
Market Cap
$203B
1M
−10.26%
S&P 500 −2.41% over same period
Volume / Avg Volume
2.4M / 2.9M
0.83× average

Price History

Closing price · USD1M6M1Y5Y
250300350400450FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 Earnings2025-092025-122026-032026-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 27.01M6M1Y5Y
222426282026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-08-04$10.1B6.29 / 5.73+4.57%Read analysis →
FY2026 Q1
Quarter ended 2026-03
2026-04-30$8.6B5.15 / 4.85−4.75%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-03—— / —+8.15%Pending
FY2025 Q3
Quarter ended 2025-09
2025-11-04—— / —+7.81%Pending
FY2025 Q2
Quarter ended 2025-06
2025-08-05—— / —−5.14%Pending
FY2025 Q1
Quarter ended 2025-03
2025-05-01—— / —−0.90%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 27 of its 5-year rangeCheap
5-year range 18.0 – 55.4 · Median 25.8
Last 4 quarters: $0 in buybacks + $5.3B in dividends, 2.60% of market cap combined
P/E (TTM)
23.3
P/B
17.4
P/S
5.4
Dividend Yield
3.21%
Earnings Reaction
Over the last 6 reports, the stock moved ±5.2% on average on the first trading day after, rising 3 times
Most recent +4.57%
Volatility & Correlation
1-year beta 0.53 · Correlation with S&P 500 0.23Low beta
Annualized volatility 29% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 4 · $4.1MNet selling $4.1M
  • 08-13Khosla RachnaSVP, Business DevelopmentSell$0.52M1,252 shares · Avg price 416.43
  • 08-11Khosla RachnaSVP, Business DevelopmentSell$0.83M2,000 shares · Avg price 412.57
  • 08-06Grygiel Nancy A.SVP & CCOSell$1.2M2,970 shares · 2 trades · Avg price 402.16
  • 08-06Miller DerekSVP, Human ResourcesSell$1.6M3,890 shares · 2 trades · Avg price 402.54
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q210.05+9.5%72.0%3.512.383.494.37
FY2026 Q18.62+5.8%68.2%2.671.821.483.34
FY2025 Q49.87+8.6%69.8%2.721.330.962.45
FY2025 Q39.56+12.4%67.8%2.533.224.255.93
FY2025 Q29.18+9.4%67.2%2.661.431.912.65
FY2025 Q18.15+9.4%63.6%1.181.730.983.20
FY2024 Q49.09+10.9%65.7%2.310.634.401.17
FY2024 Q38.50+23.2%61.1%2.052.833.315.22
FY2024 Q28.39+20.1%61.4%1.910.752.221.38
FY2024 Q17.45+22.0%57.0%0.99-0.110.46-0.21
FY2023 Q48.20+19.8%62.0%1.270.770.291.42
FY2023 Q36.90+3.8%73.8%2.021.732.513.22

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
AMGNAmgen$203B23.3+9.5%72.0%−10.26%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare
ABTAbbott Laboratories$177B33.2+7.8%56.2%−7.26%NeutralCompare